MANILA, Philippines — The 50% efficacy of the COVID-19 vaccine of China’s Sinovac Biotech is “acceptable” as it is within the World Health Organization’s (WHO) minimum requirement, the Department of Science and Technology (DOST) said on Thursday.
Brazilian researchers reportedly said CoronaVac, Sinovac’s vaccine, is more than 50%effective based on trial data.
“The 50% efficacy is acceptable because that is the minimum requirement set by the World Health Organization for a vaccine to be used by a country,” Jaime Montoya, executive director of the DOST’s Philippine Council for Health Research and Development.
“We have to also bear in mind that a vaccine efficacy may actually cha…
Keep on reading: Sinovac vaccine’s 50% efficacy is acceptable—DOST